Clinical Trials Logo
  1. Home
  2. Chronic Schizophrenia
  3. NCT00789698

Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia — PEARL 3 Ext  

Chronic Schizophrenia Clinical Trial

Official title:
A Phase 3 Randomized, Double-Blind, Active Comparator-Controlled Clinical Trial to Study the Safety and Efficacy of Lurasidone in Subjects With Schizophrenia (PEARL 3 Extension Study)

Clinical Trial Summary

Lurasidone HCl is a compound being developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is effective, tolerable, and safe as compared with quetiapine XR long term among schizophrenic outpatients with chronic schizophrenia.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00789698
Study type Interventional
Source Sunovion
Contact
Status Completed
Phase Phase 3
Start date December 2008
Completion date July 2011
View Details
See also
  Status Clinical Trial Phase
Completed NCT00161044 - An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizophrenia and Persistent Deficit Symptoms N/A
Completed NCT01450514 - POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia Phase 2
Completed NCT05809882 - Study of Experience of High-frequency Repetitive Transcranial N/A
Recruiting NCT05948696 - Experience of Horticultural Group Therapy Among People With Chronic Schizophrenia
Completed NCT06206798 - Resourcefulness Group Intervention on Recovery and Quality of Life N/A
Completed NCT01761383 - Role of Nintendo Wii in Improving Negative Symptoms and Quality of Life in Chronic Schizophrenia N/A
Completed NCT01891929 - Cognitive Remediation and Sheltered Employment in Schizophrenia N/A
Completed NCT03275909 - Integrated Psychological Therapy for Chronic Schizophrenia N/A
Completed NCT02298985 - Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients Phase 4
Recruiting NCT00525863 - Oxygen Therapy in Schizophrenia Phase 3
Completed NCT02624167 - A Study to Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia Phase 2
Recruiting NCT06349369 - Effect of tDCS on Inflammatory Biomarkers in Chronic Schizophrenia N/A
Completed NCT02421146 - The Effect of Transcranial Direct Current Stimulation on Human Brains: A Neuroimaging Study N/A
Active, not recruiting NCT00664274 - Relation of Catechol-O-methyltransferase (COMT) Genotype and Response to Cognitive Remediation Schizophrenia N/A
Terminated NCT00148616 - Memantine for the Treatment of Cognitive Dysfunction and Negative Symptoms in Patients With Chronic Schizophrenia Phase 3